Clinical Trial Update: The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression [Phase 2]

View source ↗

Summary

Phase 2 study update for Ammoxetine Hydrochloride Enteric-coated Tablets in Major Depressive Disorder is in progress with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ammoxetine Hydrochloride Enteric-coated Tablets (ammoxetine hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: UNKNOWN